Cargando…

Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time?

Transfer of select, medically refractory acute respiratory distress syndrome patients to lung transplant centers requires extensive resources. Here, we report 270 consecutive lung transplant patient referrals to our center for medically refractory ARDS from June 2021 to April 2022, following the imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerier, Emily J., Toyoda, Takahide, McNulty, Colleen, O’Boye, Anne, Kurihara, Chitaru, Bharat, Ankit, Nadig, Nandita R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489292/
https://www.ncbi.nlm.nih.gov/pubmed/37693304
http://dx.doi.org/10.1097/CCE.0000000000000965
_version_ 1785103648600096768
author Cerier, Emily J.
Toyoda, Takahide
McNulty, Colleen
O’Boye, Anne
Kurihara, Chitaru
Bharat, Ankit
Nadig, Nandita R.
author_facet Cerier, Emily J.
Toyoda, Takahide
McNulty, Colleen
O’Boye, Anne
Kurihara, Chitaru
Bharat, Ankit
Nadig, Nandita R.
author_sort Cerier, Emily J.
collection PubMed
description Transfer of select, medically refractory acute respiratory distress syndrome patients to lung transplant centers requires extensive resources. Here, we report 270 consecutive lung transplant patient referrals to our center for medically refractory ARDS from June 2021 to April 2022, following the implementation of clinical care pathways for intake of these patients. Eighty-seven of 270 patients (32.2%) met screening criteria and were evaluated for transfer within a median of 12 days, during which 38 of 87 patients (43.7%) died and 12 of 87 patients (13.8%) transferred elsewhere. Thirty-seven of 87 patients (42.5%) were accepted for transfer of which 16 of 37 patients (43.2%) successfully transferred to our center with a median transfer waiting period of 12 days. Because of resource constraints, 21 of 37 accepted patients (56.8%) could not be transferred of which 9 of 21 patients (42.9%) died while waiting. Nine of 16 transferred patients (56.2%) eventually underwent lung transplantation with over 80% 6-month survival. ARDS patients referred for transplantation have high risk of mortality and, therefore, require well-described pathways for evaluation and transfer.
format Online
Article
Text
id pubmed-10489292
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104892922023-09-09 Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time? Cerier, Emily J. Toyoda, Takahide McNulty, Colleen O’Boye, Anne Kurihara, Chitaru Bharat, Ankit Nadig, Nandita R. Crit Care Explor Letter to the Editor Transfer of select, medically refractory acute respiratory distress syndrome patients to lung transplant centers requires extensive resources. Here, we report 270 consecutive lung transplant patient referrals to our center for medically refractory ARDS from June 2021 to April 2022, following the implementation of clinical care pathways for intake of these patients. Eighty-seven of 270 patients (32.2%) met screening criteria and were evaluated for transfer within a median of 12 days, during which 38 of 87 patients (43.7%) died and 12 of 87 patients (13.8%) transferred elsewhere. Thirty-seven of 87 patients (42.5%) were accepted for transfer of which 16 of 37 patients (43.2%) successfully transferred to our center with a median transfer waiting period of 12 days. Because of resource constraints, 21 of 37 accepted patients (56.8%) could not be transferred of which 9 of 21 patients (42.9%) died while waiting. Nine of 16 transferred patients (56.2%) eventually underwent lung transplantation with over 80% 6-month survival. ARDS patients referred for transplantation have high risk of mortality and, therefore, require well-described pathways for evaluation and transfer. Lippincott Williams & Wilkins 2023-09-07 /pmc/articles/PMC10489292/ /pubmed/37693304 http://dx.doi.org/10.1097/CCE.0000000000000965 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Letter to the Editor
Cerier, Emily J.
Toyoda, Takahide
McNulty, Colleen
O’Boye, Anne
Kurihara, Chitaru
Bharat, Ankit
Nadig, Nandita R.
Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time?
title Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time?
title_full Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time?
title_fullStr Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time?
title_full_unstemmed Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time?
title_short Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time?
title_sort single-center experience with lung transplant evaluation referrals of acute respiratory distress syndrome patients during the covid-19 pandemic: how do you make up for lost time?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489292/
https://www.ncbi.nlm.nih.gov/pubmed/37693304
http://dx.doi.org/10.1097/CCE.0000000000000965
work_keys_str_mv AT cerieremilyj singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime
AT toyodatakahide singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime
AT mcnultycolleen singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime
AT oboyeanne singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime
AT kuriharachitaru singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime
AT bharatankit singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime
AT nadignanditar singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime